What can be achieved?

Pharmacokinetics of drug and metabolites in different regions of the lungs

Research and identification of unknown metabolites related to efficacy or toxicity events

Untargeted differenial analysis in eyes to discover potential biomarkers

Study different form of drug administration and the impact into the localization (aerosol, dry powder, etc…)

pulmonary Imaging mass spec

What are our advantages?

Quantify drug and metabolites in different parts of the lung

Molecular immuno-histology

Ability to overlay both molecular and spatial information

Efficacy and safety biomarkers monitoring

High resolution Mass Spectrometers (R>200,000)